30 results
6-K
EX-99.2
PRFX
PainReform Ltd
15 May 24
Condensed Financial Statements
4:15pm
to pursue and how much to fund each program in response to the scientific and clinical success of each drug candidate, as well as an assessment of each drug
424B4
PRFX
PainReform Ltd
17 Apr 24
Prospectus supplement with pricing info
4:14pm
for the future and the extent to which they have been implemented, an assessment of our management, the general conditions of the securities markets
F-1/A
PRFX
PainReform Ltd
15 Apr 24
Registration statement (foreign) (amended)
9:41am
they have been implemented, an assessment of our management, the general conditions of the securities markets at the time of the offering
F-1
PRFX
PainReform Ltd
1 Mar 24
Registration statement (foreign)
4:34pm
business plans for the future and the extent to which they have been implemented, an assessment of our management, the general conditions
6-K
EX-99.2
esaku2rlu3vxil4po
15 Nov 23
Condensed Financial Statements
4:09pm
6-K
EX-99.2
l0fe6
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.2
lvtuf c2zja
15 May 23
Condensed Financial Statements
4:51pm
6-K
EX-99.2
xpagc
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
EX-99.2
e29ju77xzvs5xs
15 Aug 22
Current report (foreign)
6:16pm
6-K
EX-99.2
bny45vtm3 j490njsqbj
16 May 22
Condensed Financial Statements
4:31pm
6-K
EX-99.2
yi5jm
15 Nov 21
Condensed Financial Statements
4:15pm
6-K
EX-99.2
utm133ejc cccjfzua
16 Aug 21
Current report (foreign)
8:17am
6-K
EX-99.2
jik5ydmu
13 May 21
PAINREFORM LTD. Condensed UNAUDITED FINANCIAL STATEMENTS
9:18am
20-F
ueq2crgjz92 3s07h3
18 Mar 21
Annual report (foreign)
9:03am
6-K
EX-10.3
8ed36gpbv85 kh
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
EX-99.1
dihd8
19 Oct 20
PainReform Highlights Surgical Advantages of PRF-110
1:37pm
424B3
oae9sudmzoxs3 k0v
30 Sep 20
Prospectus supplement
4:42pm
6-K
EX-99.2
kju927wzs9yawu fz
30 Sep 20
Condensed Financial Statements
4:32pm